Topiramate Tablet, Film Coated
FDA Label NDC 65841-649

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Topiramate (NDC 65841-649). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 65841-647-14 in bottle of 60 tablets

Topiramate Tablets USP, 25 mg

60 tablets

Rx only

Topiramate Tablets (85c62092 3b8c 43af A980 E2d959e0c341 01)

Topiramate Tablets (85c62092 3b8c 43af A980 E2d959e0c341 01)

NDC 65841-648-14 in bottle of 60 tablets

Topiramate Tablets USP, 50 mg

60 tablets

Rx only

Topiramate Tablets (85c62092 3b8c 43af A980 E2d959e0c341 02)

Topiramate Tablets (85c62092 3b8c 43af A980 E2d959e0c341 02)

NDC 65841-649-14 in bottle of 60 tablets

Topiramate Tablets USP, 100 mg

60 tablets

Rx only

Topiramate Tablets (85c62092 3b8c 43af A980 E2d959e0c341 03)

Topiramate Tablets (85c62092 3b8c 43af A980 E2d959e0c341 03)

NDC 65841-650-14 in bottle of 60 tablets

Topiramate Tablets USP, 200 mg

60 tablets

Rx only

Topiramate Tablets (85c62092 3b8c 43af A980 E2d959e0c341 04)

Topiramate Tablets (85c62092 3b8c 43af A980 E2d959e0c341 04)

* Please review the disclaimer below.